Thrombosis Is Reduced by Inhibition of COX-1, but Unaffected by Inhibition of COX-2, in an Acute Model of Platelet Activation in the Mouse
Author Information
Author(s): Paul C. Armstrong, Nicholas S. Kirkby, Zetty N. Zain, Michael Emerson, Jane A. Mitchell, Timothy D. Warner
Primary Institution: The William Harvey Research Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London
Hypothesis
Does acute inhibition of COX-2 in the circulation increase thrombosis?
Conclusion
Inhibition of COX-1 reduces thrombus formation induced by collagen, but acute inhibition of COX-2 does not affect thrombosis.
Supporting Evidence
- Aspirin significantly reduced the time to peak and total peak area of the response to collagen.
- Diclofenac inhibited thrombus formation in response to collagen but not U46619.
- Parecoxib had no effect on thrombus formation caused by either agonist.
Takeaway
When we give mice certain drugs, blocking COX-1 helps stop blood clots, but blocking COX-2 doesn't seem to change anything.
Methodology
A non-lethal model of platelet-driven thromboembolism in mice was used to assess the effects of aspirin, diclofenac, and parecoxib on thrombus formation.
Limitations
The study was conducted in a mouse model, which may not fully replicate human physiology.
Participant Demographics
Male BALB/c mice, 7-8 weeks old, weighing 20-25 g.
Statistical Information
P-Value
p<0.01
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website